This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS Aug. 2, 2011
ASCLS eNewsBytes
Aug. 2, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources


Flu 'super antibody' may bring universal shot closer
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have found a flu "super antibody" called FI6 that can fight all types of influenza A viruses that cause disease in humans and animals and say their discovery may be a turning point in the development of new flu treatments. Researchers used a new method aimed at beating "needle-in-a-haystack-type-odds" and managed to identify an antibody from a human patient which neutralizes both main groups of influenza A viruses. More



Study: New points of attack on breast cancer not fueled by estrogen
Media-Newswire.com    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women. In a new study, scientists provide the first details of the cancer cell machinery that carries out the hormone's relentless growth orders. More

STA Coag ConneXion

STA Coag ConneXion is an easy to use, Windows 7 based user interface that offers comprehensive QC management, remote QC capability and standardized result reporting with the use of expert rules for auto validation. For more information on STA Coag ConnneXion, visit www.stago-us.com.


Rapid, cheap HIV test finds success as first of its kind tested in the field
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The first field trial for a "lab on a chip" accurately detected both HIV and syphilis among a Rwandan population, researchers reported. Blood samples injected into the clear plastic, credit card-shaped device produced results within 20 minutes. This kind of test could offer a faster, cheaper and easier way to detect infectious diseases that afflict developing countries. More

A breath of fresh air in diagnostics

Providing the accurate, dependable allergy, urinalysis and auto-immune results you require. Delivering the cost-effective test results you value.
MORE


Bacterial resistance to antibiotics: The more they resist, the more they divide
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The number of multiresistant strains of bacteria in hospitals is increasing. Bacteria acquire resistance to antibiotics through mutations in their chromosomes and by incorporating new genes, either from the surrounding environment or from other bacteria. Now, a research team has found when both mechanisms of resistance are playing out in the bacterium E. coli, its ability to survive and reproduce is increased. More

Doctors begin major stem cell trial for multiple sclerosis patients
BBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A major clinical trial will investigate whether stem cells can be safely used to treat multiple sclerosis. It is hoped eventually to slow, stop or even reverse the damage MS causes to the brain and spinal cord. The trial, involving up to 150 patients across Europe, is due to start later this year. More

At Phadia®, we see things differently.

See what we see. For cutting-edge testing technologies for allergic and autoimmune diseases… Look no further than Phadia. Contact us today at 800.346.4364 or www.phadia.us.


Study: Dense breast hike risk of aggressive cancer
MedPage Today (free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Increasing breast density conferred a progressively greater risk of breast cancer with aggressive characteristics in postmenopausal women, according to a study. Women with more than 50 percent breast density on mammographic study had triple the risk of breast cancer compared with women who had less than 10 percent density. More

Social media tools aid public health officials
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Dr. Raina M. Merchant, an emergency physician and assistant professor at the Pearlman School of Medicine at the University of Pennsylvania, noticed her patients were becoming far more social media savvy than the health care system they were being treated in. Merchant told Kaiser Health News that after reviewing news stories on the use of social media during disasters and seeing her patients turn to Twitter and Facebook for guidance on health issues, "it made a lot of sense to think about how to use these tools before the moment of need." More

Looking for new Controls?

Fujirebio Diagnostics, Inc.introduces a novel Tumor Marker Control (HE4, AFP, CEA, CA15-3, CA19-9, CA125, Ferritin, PSA, and free PSA) and a new Vitamin D Control (25(OH) Vitamin D2 and 25(OH) Vitamin D3.) MORE


Study: Increased muscle mass may lower risk of pre-diabetes
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A recent study found that the greater an individual's total muscle mass, the lower the person's risk of having insulin resistance, the major precursor of type 2 diabetes. With recent dramatic increases in obesity worldwide, the prevalence of diabetes, a major source of cardiovascular morbidity, is expected to accelerate. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • July 26, 2011
  • July 19, 2011
  • July 12, 2011
  • July 5, 2011
  • June 28, 2011
  •  RSS Feed
    Most popular articles